Several review articles have shown that AS is related to epigenetic events [8], therapeutic targets [9], and splicing variants of particular classical molecules, such as B-Raf proto-oncogene (BRAF) [10] and vascular endothelial growth factor A (VEGF-A) in CRC [11]. The gene discussed is BRAF; the disease is colorectal carcinoma.